J Matthew Meinig Selected Research

Neoplasms (Cancer)

2/2015

Anticancer/antiviral agent Akt inhibitor-IV massively accumulates in mitochondria and potently disrupts cellular bioenergetics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Matthew Meinig Research Topics

Disease

3	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2017
2	Infections 03/2023 - 01/2023
2	Anthrax 01/2023 - 10/2022
1	Poxviridae Infections 02/2024
1	Smallpox (Variola) 02/2024
1	Mpox (monkeypox) 02/2024
1	Melioidosis 03/2023
1	Ebola Hemorrhagic Fever 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2017
1	Neoplasms (Cancer) 02/2015

Drug/Important Bio-Agent (IBA)

2	GC 1 compoundIBA 01/2019 - 01/2017
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 02/2024
1	NucleosidesIBA 02/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2023
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2023
1	delafloxacinIBA 01/2023
1	Capsules (Microcapsules)IBA 10/2022
1	EnzymesIBA 10/2022
1	Monoclonal AntibodiesIBA 01/2020
1	Thyroid HormonesIBA 01/2019
1	GliotoxinIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 02/2015

Therapy/Procedure

3	Therapeutics 02/2024 - 01/2020
1	Withholding Treatment 03/2023